Fisher Asset Management LLC Purchases 8,298 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Fisher Asset Management LLC increased its stake in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 112.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 15,696 shares of the medical research company's stock after purchasing an additional 8,298 shares during the quarter. Fisher Asset Management LLC's holdings in IQVIA were worth $3,085,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Capital Performance Advisors LLP bought a new stake in shares of IQVIA in the third quarter valued at approximately $27,000. Avior Wealth Management LLC raised its holdings in IQVIA by 117.6% during the 3rd quarter. Avior Wealth Management LLC now owns 161 shares of the medical research company's stock valued at $38,000 after acquiring an additional 87 shares during the period. Synergy Asset Management LLC purchased a new stake in shares of IQVIA during the fourth quarter worth $33,000. Assetmark Inc. boosted its holdings in shares of IQVIA by 612.5% in the third quarter. Assetmark Inc. now owns 228 shares of the medical research company's stock worth $54,000 after acquiring an additional 196 shares during the period. Finally, Ashton Thomas Securities LLC purchased a new position in shares of IQVIA in the third quarter valued at $57,000. Hedge funds and other institutional investors own 89.62% of the company's stock.

IQVIA Trading Down 0.2 %

NYSE:IQV traded down $0.40 during trading hours on Thursday, reaching $185.45. The company's stock had a trading volume of 1,215,605 shares, compared to its average volume of 1,210,030. The company has a debt-to-equity ratio of 2.12, a quick ratio of 0.84 and a current ratio of 0.84. The firm has a market capitalization of $32.70 billion, a price-to-earnings ratio of 24.73, a PEG ratio of 1.99 and a beta of 1.50. The firm has a 50-day simple moving average of $198.24 and a 200-day simple moving average of $213.66. IQVIA Holdings Inc. has a 1 year low of $179.28 and a 1 year high of $261.73.

IQVIA (NYSE:IQV - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The medical research company reported $2.90 EPS for the quarter, missing the consensus estimate of $3.11 by ($0.21). IQVIA had a return on equity of 28.81% and a net margin of 8.91%. Research analysts expect that IQVIA Holdings Inc. will post 10.84 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have commented on IQV shares. Citigroup cut their target price on IQVIA from $225.00 to $210.00 and set a "neutral" rating for the company in a research note on Tuesday. UBS Group cut their price objective on shares of IQVIA from $260.00 to $255.00 and set a "buy" rating for the company in a research report on Friday, February 7th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $270.00 target price on shares of IQVIA in a report on Monday, February 10th. William Blair reissued an "outperform" rating on shares of IQVIA in a report on Wednesday, December 11th. Finally, Bank of America decreased their price target on shares of IQVIA from $255.00 to $235.00 and set a "buy" rating on the stock in a report on Friday, December 13th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $249.05.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.